Major vault protein LRP-related multidrug resistance

European Journal of Cancer

Volumn 32, Issue 6, 1996, Pages 979-984

  Izquierdo, M A ^a,b   Scheffer, G L ^b   Flens, M J ^b   Schroeijers, A B ^b   Van Der Valk, P ^b   Scheper, R J ^b  

^a Hospital Duran i Reynalds   (Spain)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; CARBOPLATIN; CARRIER PROTEIN; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; GENE PRODUCT; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MELPHALAN; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CHILDHOOD CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CARCINOMA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ISOLATION; REVIEW;

EID: 0029931599     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00053-6     Document Type: Article

References (40)

1. Vendrik CPJ, Bergers JJ, De Jong WH, Steerenberg PA. Resistance to cytostatic drugs at the cellular level. Cancer Chemother Pharmacol 1992, 29, 413-429.
2. Gerlach JH, Kartner N, Bell DR, Ling V. Multidrug resistance. Cancer Surv 1986, 5, 25-46.
3. Gottesman JH, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 1993, 62, 385-427.
4. Childs S, Ling V. The MDR superfamily of genes and its biological implications. In De Vita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadelphia, J.B. Lippincott Company, 1994, 21-36.
5. Gros P, Neriah YB, Croop JM, Housman DE. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 1986, 323, 728-731.
6. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994, 54, 357-361.
7. Higgins CF. ABC transporters - From microorganisms to man. Annu Rev Cell Biol 1992, 8, 67-113.
8. Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993, 53, 1475-1479.
9. Scheffer GL, Wijngaard PLJ, Flens MJ, et al. The drug resistance-related protein LRP is the human major vault protein. Nature Med 1995, 1, 578-582.
10. Rome LH, Kedersha NL, Chugani DC. Unlocking vaults: organelles in search of a function. Trends Cell Biol 1991, 1, 47-50.
11. Kedersha NL, Rome LH. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol 1986, 103, 699-709.
12. Cole SP. The 1991 Merck Frosst Award. Multidrug resistance in small cell lung cancer [Review]. Can J Physiol Pharmacol 1992, 70, 313-329.
13. Kuiper CM, Broxterman HJ, Baas F, et al. Drug transport variants without P-glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin. J Cell Pharmocol 1990, 1, 35-41.
14. Futscher BW, Abbaszadegan MR, Domann F, Dalton WS. Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem Pharmacol 1994, 47, 1601-1606.
15. Versantvoort CHM, Withoff S, Broxterman HJ, et al. Resistance-associated factors in human small-cell lung-carcinoma GLC(4) sub-lines with increasing adriamycin resistance. Int J Cancer 1995, 61, 375-380.
16. Flens MJ, Izquierdo MA, Scheffer GL, et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994, 54, 4557-4563.
17. Slovak ML, Ho JP, Bhardwaj G, Kurz EU, Deeley RG, Cole SPC. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res 1993, 53, 3221-3225.
18. Slovak ML, Ho JP, Cole SPC, et al. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res 1995, 55, 4214-4219.
19. Shao Y, de Giuli R, Wyler B, Lehnert M. Overexpression of MDR1/P-glycoprotein and MRP but not LRP is mutually exclusive in multidrug resistant human myeloma cells selected with doxorubicin. Proc Am Assoc Cancer Res 1995, 36, 337 (abstract 2006).
20. Kedersha NL, Rome LH. cDNA cloning and disruption of the major vault protein alpha (mvpA) in Dictyostalium discoideum. J Biol Chem 1993, 268, 15356-15360.
21. Kickhoefer VA, Rome LH. The sequence of a cDNA encoding the major vault protein from Rattus norvegicus. Gene 1994, 151, 257-260.
22. Kedersha NL, Miquel M-C, Bittner D, Rome LH. Vaults II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol 1990, 110, 895-901.
23. Kedersha NL, Heuser JE, Chugani DC, Rome LH. Vaults III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J Cell Biol 1991, 112, 225-235.
24. Chugani DC, Rome LH, Kedersha NL. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Sci 1993, 106, 23-29.
25. Izquierdo MA, Scheffer GL, Flens MJ, et al. Expression of the non-P-glycoprotein multidrug-resistance associated protein LRP in normal human tissues and tumors. Am J Pathol 1996, 148, 877-887.
26. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors. Proc Natl Acad Sci USA 1987, 84, 265-269.
27. Cordon-Cardo C, O'Brien JP, Casals D, Bertino JR, Melamed MR. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissue. J Histochem Cytochem 1990, 38, 1277-1287.
28. Zaman GJR, Versantvoort CHM, Smit JJM, et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993, 53, 1747-1750.
29. Izquierdo MA, Shoemaker RH, Flens MJ, et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer 1996, 65, 230-238.
30. Wu L, Smythe AM, Stinson SF, et al. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res 1992, 52, 3029-3034.
31. Ramani P, Dewchand H. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma. J Pathol 1995, 175, 13-22.
32. Schadendorf D, Makki A, Stahr C, et al. Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 1995, 147, 1545-1552.
33. Dingemans AMC, van Ark-Otte J, van der Valk P, Scheper RJ, Postmus PE, Giaccone G. Expression of the lung resistance-related protein (LRP) in lung cancer. Eur J Cancer 1995, 31(Suppl. 5), 28 (abstract 120).
34. Klumper E, de Boer ML, Pieters R, et al. Non-P-glycoprotein mediated resistance to anthracyclines is associated with the expression of a 110 kD protein in relapsed childhood acute lymphoblastic leukemia. In Klumper E, ed. Thesis. Drug Resistance and Relapsed Leukemia. Amsterdam, VU University Press, 1995, 117-130.
35. List A, Spier CS, Grogan TM, et al. Overexpression of the major vault transporter protein LRP predicts treatment outcome in AML. Blood 1996, in press.
36. Hart SM, Ganeshaguru K, Scheper RJ, Hoffbrand AV, Mehta AB. Expression of the human major vault protein in haematological malignancies. Am Soc Haematol 1995, abstract.
37. Izquierdo MA, van der Zee AGJ, Vermorken JB, et al. Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst 1995, 87, 1230-1237.
38. Hindenburg AA, Gervasoni JE Jr, et al. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res 1989, 49, 4607-4614.
39. Gervasoni JE Jr, Fields SZ, Krishna S, et al. Subcellular distribution of daunorubicin in P-glycoprotein-positive and negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res 1991, 51, 4955-4963.
40. Schuurhuis GJ, Broxterman HJ, de Lange JHM, et al. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br J Cancer 1991, 64, 857-861.